Here are six takeaways:
1. The market is expected to grow at a compound annual growth rate of 8 percent to 2018.
2. The increasing prevalence of chronic diseases as well as a growing aging population will spur market growth.
3. Other market drivers include an increasing healthcare expenditure and purchasing power parity.
4. The costliness of implantable devices, however, will serve as a barrier to market growth.
5. The orthopedic segment is leading the market, set to reach revenue of $38.04 million by 2018.
6. Zimmer Biomet, Stryker and Abbott Laboratories lead the market.
More articles on devices:
Massachusetts orthopedic surgeons receive $33M on hip devices: 4 key notes
Titan Spine launches nanoLOCK surface technology nationwide: 5 highlights
Dr. Raphael Roybal to share experience with FLXfit expandable cage: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
